The SeniorCare Investor, May 2011

More CCRCs For Sale– Better To Act Quickly In Distressed CCRC Sales When the Great Recession hit, with the subsequent decline in single family home values and sales, stock portfolios, and investment returns for the elderly in general, the impact on the CCRC...

The Health Care M&A Monthly: Takeda Buys Nycomed–

Pays $13.6 Billion To Buy Into Emerging Markets   After coyly denying its intentions for a few weeks, Japan’s Takeda Pharmaceutical Co. (T: 4502) announced that it is buying Nycomed from its private equity owners for €9.6 billion ($13.6 billion). Based in Switzerland,...